Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.610
+0.050 (1.95%)
Mar 20, 2026, 12:00 PM EDT - Market open
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $188.57 million as of March 20, 2026. Its market cap has increased by 37.10% in one year.
Market Cap
188.57M
Enterprise Value
-55.28M
1-Year Change
37.10%
Ranking
Category
Stock Price
$2.61
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $188.57M, a decrease of -67.90%. That is a compound annual growth rate of -17.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 165.76M | 89.63% |
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAB Biotherapeutics | 192.59M |
| Arcturus Therapeutics Holdings | 191.00M |
| Caribou Biosciences | 190.38M |
| MacroGenics | 184.31M |
| Cibus | 184.06M |
| NeOnc Technologies Holdings | 181.54M |
| Galectin Therapeutics | 180.52M |
| Sutro Biopharma | 179.81M |